CIK 0001253689
- Non-accelerated filer
- Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +1 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 5,209 shares (grant or award)
- 4 Grant or award Director acquired 3,334 shares (grant or award)
- 4 Grant or award Director acquired 4,584 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 5,191 shares (grant or award)
- 4 Grant or award Director acquired 4,238 shares (grant or award)
- 4 Grant or award Director acquired 5,827 shares (grant or award)
- 4 Grant or award Director acquired 9,167 shares (grant or award)
- 4 Grant or award Director acquired 8,167 shares (grant or award)
- 4 Grant or award Director acquired 6,667 shares (grant or award)
- 4 Open-market buy Chief Medical Officer bought 65,403 shares at $1.38 ($90,256)
Page 4 of 15 · 293 filings